PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

PharmaCyte Biotech (PMCB) Depreciation and Depletion (2009 - 2010)

Updated

PharmaCyte Biotech (PMCB) reported Depreciation and Depletion of $24,659 for FY2012 (year ended Apr 30, 2012).

Analysis

PharmaCyte Biotech (PMCB) Depreciation and Depletion (2009 - 2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 PharmaCyte Biotech 4.29 Mn -68.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2010 32,700.00
Oct 31, 2009 32,700.00
Jul 31, 2009 32,906.00
Apr 30, 2009 21,979.00
Jan 31, 2009 2,292.00
API Access

PharmaCyte Biotech Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=PMCB&period=max&api_key=YOUR_API_KEY